Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Erlotinib | 0.01 | uM | 7 | 312.50 | 169.63 | 273.67 | 265.67 | 1.0253 | 1.0692 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 7 | 312.50 | 169.63 | 249.67 | 265.67 | 0.9421 | 0.8355 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 7 | 312.50 | 169.63 | 334.33 | 265.67 | 1.2571 | 1.8821 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 7 | 312.50 | 169.63 | 209.33 | 265.67 | 0.7928 | 0.4121 |
| SK-BR-3 | Erlotinib | 1 | uM | 7 | 312.50 | 169.63 | 248.33 | 265.67 | 0.9302 | 0.7724 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 7 | 312.50 | 169.63 | 221.33 | 265.67 | 0.8366 | 0.5250 |
| SK-BR-3 | Erlotinib | 10 | uM | 7 | 312.50 | 169.63 | 176.33 | 265.67 | 0.6741 | 0.1280 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 7 | 312.50 | 169.63 | 242.00 | 265.67 | 0.9010 | 0.6583 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 7 | 625.00 | 354.63 | 694.00 | 664.00 | 1.0452 | 1.1005 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 7 | 625.00 | 354.63 | 811.00 | 664.00 | 1.2215 | 1.4984 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 7 | 625.00 | 354.63 | 649.33 | 664.00 | 0.9757 | 0.9394 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 7 | 625.00 | 354.63 | 658.00 | 664.00 | 0.9886 | 0.9729 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 7 | 625.00 | 354.63 | 693.00 | 664.00 | 1.0457 | 1.1093 |
| SK-BR-3 | Erlotinib | 1 | uM | 7 | 625.00 | 354.63 | 595.67 | 664.00 | 0.8952 | 0.7665 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 7 | 625.00 | 354.63 | 524.33 | 664.00 | 0.7906 | 0.5453 |
| SK-BR-3 | Erlotinib | 10 | uM | 7 | 625.00 | 354.63 | 431.33 | 664.00 | 0.6487 | 0.2374 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 7 | 625.00 | 354.63 | 465.00 | 664.00 | 0.6998 | 0.3467 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 7 | 1250.00 | 859.67 | 1936.33 | 1832.08 | 1.0682 | 1.1582 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 7 | 1250.00 | 859.67 | 1855.33 | 1832.08 | 1.0158 | 1.0361 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 7 | 1250.00 | 859.67 | 1801.33 | 1832.08 | 0.9810 | 0.9581 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 7 | 1250.00 | 859.67 | 1911.67 | 1832.08 | 1.0452 | 1.0896 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 7 | 1250.00 | 859.67 | 1799.67 | 1832.08 | 0.9819 | 0.9663 |
| SK-BR-3 | Erlotinib | 1 | uM | 7 | 1250.00 | 859.67 | 1628.00 | 1832.08 | 0.8865 | 0.7830 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 7 | 1250.00 | 859.67 | 1436.33 | 1832.08 | 0.7882 | 0.6089 |
| SK-BR-3 | Erlotinib | 10 | uM | 7 | 1250.00 | 859.67 | 949.00 | 1832.08 | 0.5202 | 0.0931 |